Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
66°
Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
McKesson Corp
(NY:
MCK
)
560.73
+2.70 (+0.48%)
Official Closing Price
Updated: 7:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about McKesson Corp
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
S&P 500 Flirts With 5,000 As Magnificent 7 Tops $13 Trillion, NYCB Sinks: What's Driving Markets Wednesday?
February 07, 2024
Wednesday is a bullish day on Wall Street, with major large-cap indices extending record highs, aided by robust corporate earnings. Despite the overall market optimism, concerns linger within segments...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
McKesson Earnings Are Imminent; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
February 07, 2024
McKesson Corporation (NYSE: MCK) is expected to release earnings results for its third quarter, after the closing bell on Feb. 7, 2024.
Via
Benzinga
Earnings Scheduled For February 7, 2024
February 07, 2024
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via
Benzinga
Fear & Greed Index Remains In 'Greed' Zone Following Earnings Reports; Dow Jumps Over 100 Points
February 07, 2024
The CNN Money Fear and Greed index showed a slight improvement in the overall market sentiment, while the index remained in the "Greed" zone on Tuesday. U.S. stocks closed higher on Tuesday, as...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Earnings Preview: McKesson
February 06, 2024
Via
Benzinga
Here's How Much $1000 Invested In McKesson 5 Years Ago Would Be Worth Today
January 19, 2024
Via
Benzinga
Wall Street's Top 10 Stock Calls This Week - Saturday, Feb. 3
February 03, 2024
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Jan. 29 through Feb. 2.
Via
Talk Markets
3 Hidden Healthcare Stocks Poised for a Breakout This Year
January 30, 2024
As the market preferences start to switch toward stable and defensive names like healthcare, these stocks could help your portfolio.
Via
InvestorPlace
Peering Into McKesson's Recent Short Interest
January 15, 2024
Via
Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $12,000 Today
January 05, 2024
Via
Benzinga
Check Out What Whales Are Doing With MCK
January 03, 2024
Via
Benzinga
Exceeding Expectations: McKesson Achieves Strong Performance and Rewards Investors
January 02, 2024
On January 02, 2024, McKesson (NYSE:MCK) will distribute a dividend payout of $0.62 per share, equating to an annualized dividend yield of 0.55%. Shareholders who owned the stock before the ex-dividend...
Via
Benzinga
How Is The Market Feeling About McKesson?
December 25, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning McKesson Stock In The Last 5 Years
December 18, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About McKesson
December 11, 2023
Via
Benzinga
Silver Economy Successes: 3 Stocks Benefitting From an Aging Population
December 27, 2023
Explore our in-depth analysis of aging population stocks, uncovering the opportunities and challenges in this sector.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Calliditas Therapeutics Scores Complete FDA Approval, Broader Label For Lead Kidney Disease Drug
December 21, 2023
The FDA approved Calliditas Therapeutics AB's (NASDAQ: CALT) Tarpeyo (budesonide) delayed-release capsules to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy...
Via
Benzinga
Exposures
Product Safety
How Is The Market Feeling About McKesson?
December 08, 2023
Via
Benzinga
This 1 Surprising New Tailwind Is Lifting These 2 Evergreen Stocks
December 04, 2023
New growth drivers are helping to propel these reliable and steady businesses.
Via
The Motley Fool
Here's How Much $100 Invested In McKesson 15 Years Ago Would Be Worth Today
December 01, 2023
Via
Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
November 22, 2023
Via
Benzinga
(MCK) - Analyzing McKesson's Short Interest
November 22, 2023
Via
Benzinga
Peering Into McKesson's Recent Short Interest
November 06, 2023
Via
Benzinga
Analyst Ratings for McKesson
November 03, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
Via
Benzinga
3 Biotech Stocks You’ll Regret Not Buying Soon: November 2023
November 14, 2023
The global biotechnology market could nearly triple by 2030. Investors should consider buying these biotech stocks before they explode.
Via
InvestorPlace
Qualcomm, Merck And 2 Other Stocks Insiders Are Selling
November 10, 2023
The Nasdaq 100 closed lower by more than 100 points on Thursday. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
3 Evergreen Stocks for Long-term Wealth Generation
November 09, 2023
Finding solid long-term stocks that aren't value traps is tough, but these stocks have great fundamentals and equally compelling prospects.
Via
InvestorPlace
Stock Market Rally Back In Force As Treasury Yields Plunge; Arista, Palantir Among Winners: Weekly Review
November 03, 2023
Bulls are back in control as the major indexes confirmed the uptrend this week.
Via
Investor's Business Daily
McKesson (MCK) Q2 2024 Earnings Call Transcript
November 02, 2023
MCK earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.